ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,330.00
0.00 (0.00%)
At close: Aug 5, 2025, 3:30 PM KST

ImmuneOncia Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Debt / Equity Ratio
0.010.010.010.000.000.00
Upgrade
Asset Turnover
0.020.020.000.180.000
Upgrade
Quick Ratio
3.003.007.757.164.8013.22
Upgrade
Current Ratio
3.063.067.907.534.8413.31
Upgrade
Return on Equity (ROE)
-22.97%-22.97%----
Upgrade
Return on Assets (ROA)
-26.25%-26.25%-21.22%-21.71%-18.57%-22.71%
Upgrade
Return on Capital (ROIC)
-31.66%-31.66%----
Upgrade
Buyback Yield / Dilution
-1117.38%-7.35%-0.64%-12.17%-904.47%0.01%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.